You are herePharma News
(11th November, 2014); The explosive organic compound pentaerythritol tetranitrate (PETN) might one day allow pregnant women to protect their daughters from developing high blood pressure (BP) before they’re born, according to an animal study published in the American Heart Association’s journal Hypertension.
(10th November, 2014); All multicellular creatures are descended from single-celled organisms. The leap from unicellularity to multicellularity is possible only if the originally independent cells collaborate. So-called cheating cells that exploit the cooperation of others are considered a major obstacle. Scientists at the Max Planck Institute for Evolutionary Biology in Plön, Germany, together with researchers from New Zealand and the USA, have observed in real time the evolution of simple self-reproducing groups of cells from previously individual cells.
(6th November, 2014; Business Wire India); Asia’s leading Discovery Research and Development organization, GVK BIO, announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment contract research organization operating out of Chennai, India.
(6th November, 2014); New Danish-led research suggests that signs of brain aging can be postponed in mice if placed on a high-fat diet. In the long term, this opens the possibility of treatment of children suffering from premature aging and patients with Alzheimer's and Parkinson's disease. The research project is headed by the Center for Healthy Aging, University of Copenhagen and the National Institute of Health.
(5th November, 2014); Today, Food Safety and Standards (Amendment) Bill, 2014 is withdrawn by government with approval of shri Narendra Modi, PM of India. It needs further amendments in bill.
Government would institutionalise a regulatory authority with full powers to oversee all-round quality standards
(4th November, 2014); Dr Harsh Vardhan, Union Health Minister, said here today that the government would institutionalise a regulatory authority with full powers to oversee all-round quality standards enforcement and consumer protection under the National Health Assurance Mission (NHAM).
Biocon Expands its Strategic Partnership with CytoSorbents for CytoSorb® to Treat SIRS and Cardiac Surgery Patients
(3rd November, 2014; Business Wire India); Biocon Ltd, Asia's premier biopharmaceuticals company, and U.S.-based CytoSorbents Corporation (OTCQB: CTSO) announced today that they have expanded the scope of their strategic partnership for CytoSorbents’ CytoSorb® cytokine reduction therapy to treat patients experiencing severe whole body inflammation, often called a Systemic Inflammatory Response Syndrome (SIRS). SIRS is caused by a wide range of life-threatening conditions seen in the intensive care unit and can also be caused by surgical interventions, particularly cardiac surgery.
(21st October, 2014; Business Wire India); GVK Biosciences (GVK BIO) – Asia’s leading integrated Discovery Research and Development organization today announced the successful completion of in-silico based alternative indications of shelved compounds for Takeda Pharmaceutical Company Limited using GVK BIO’s proprietary Drug Repurposing Platform. Taking the project to the next level, GVK BIO and Takeda have jointly agreed to evaluate the pre-clinical proof-of-concept for certain indications of selected therapeutic compounds to develop novel indications for the previously failed compounds.
(21st October, 2014); The student chapter of ISPOR at NIPER, Mohali conducted a workshop on “Critical Appraisal of Research Papers” as a part of the Third International Conference of Pharmacoeconomics and Outcome Research (held on 17-18 Oct 2014 at New Delhi). Critical appraisal of literature helps in ensuring the trustworthiness, value and relevance of published research to apply into practice.